Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT04767087

Honey and Nigella Sativa in COVID-19 Prophylaxis (HNS-COVID-PK)

Honey and Nigella Sativa in the Prophylaxis of COVID-19: A Randomized Controlled Trial

Sponsor: Sohaib Ashraf

Conditions Covid19

Interventions Honey Nigella sativa seed Placebo

Updated 5 times since 2021 Last updated: Jul 1, 2021 Started: Mar 5, 2021 Primary completion: Feb 15, 2022 Completion: Apr 15, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Covid19 and is currently ongoing. Sohaib Ashraf leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Aug 2023 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3

Status: Recruiting → Unknown Status
Sep 2021 — Aug 2023 [monthly]

Recruiting PHASE2_PHASE3
Mar 2021 — Sep 2021 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sohaib Ashraf

Data source: Sheikh Zayed Federal Postgraduate Medical Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lahore, Pakistan